ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1528

Predictors of Employment, Work Productivity Loss, Activity Impairment, and Regaining Employment in Latinos with Rheumatoid Arthritis in the United States

George A. Karpouzas1, Taylor Draper2, Elizabeth Hernandez3, Rosalinda Moran3 and Sarah Ormseth3, 1Harbor UCLA Med Ctr, Torrance, CA, 2Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, 3Rheumatology, Harbor-UCLA Medical Center, Torrance, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Employment, Hispanic patients, Workforce and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with Rheumatoid
arthritis (RA) experience declining functional ability, quality of life,
employment and work productivity. Such outcomes have been described in
homogeneous, mostly Caucasian cohorts. Our objective was to characterize
baseline determinants of employment, absenteeism, presenteeism,
work productivity loss (WPL), and activity impairment (AI) in Latinos with RA
in the US. We further explored longitudinal predictors of both maintenance of
employment, as well as of regaining employment over time.

Methods: We assessed 303 Latinos with RA and
regular follow up in a single center between 2011 and 2014. Evaluator outcomes-
including global disease activity (EGA), swollen and tender joints, sedimentation
rate (ESR)- and patient reported outcomes such as global activity (PGA),
disability (Health Assessment Questionnaire, HAQ-DI), pain, fatigue, and depression
(Patient Health Questionnaire, PHQ9) were recorded at baseline and follow-up
visits, at a median of 2 years. A Work Productivity and Activity Impairment
(WPAI) questionnaire was completed at both times. Linear and logistic regression
models evaluated predictors of outcomes of interest at baseline. Cox regression
models assessed survival of employment, regaining employment, and their
determinants longitudinally.

Results: At
baseline, 77 (25%) patients were employed; they were younger, had lower ESR,
prednisone use and numbers of concurrent synthetic disease modifying agents-DMARDs
(all <0.05). They also had lower PGA, disability, pain, fatigue, and
activity impairment (all <0.05). Higher HAQ-DI, DMARD numbers, and pain negatively
associated with employment (table 1). Fatigue and HAQ-DI strongly predicted presenteeism and WPL in those employed, while pain and PGA
additionally predicted AI in all. Those remaining employed (68%) had lower depression
scores; employment survival was further predicted by decrease in tender joints,
fatigue, and EGA. Those gaining employment (11%) were significantly younger, with
lower baseline HAQ-DI and greater changes in HAQ-DI (all, p<0.05).

Conclusion: Few Latinos
with RA are gainfully employed. HAQ-DI is a durable predictor of baseline
employment, work productivity loss and activity impairment; its change- in
those unemployed- further determines who regains employment. Patient-reported
outcomes such as fatigue, pain, and PGA significantly and differentially
contribute to several aspects of work productivity and activity impairment.

Table 1: Independent, multivariate contributors to Employment, Absenteeism, Presenteeism, Work Productivity Loss and Activity
Impairment in Latinos with RA in the US

Employment

Absenteeism

Presenteeism

Work

Productivity Loss

Activity Impairment

Univariate

Factors

OR

(95% CI)

p

B

(95% CI)

p

B

(95% CI)

p

B

(95% CI)

p

B

(95% CI)

p

Age

0.98

(0.95-1.01)

0.2

-0.04

(-0.07,-0.008)

0.02

–

–

–

–

–

–

SJC

1.13

(1.05-1.21)

0.001

–

–

0.11

(-1.46-1.67)

0.89

-0.26

(-2.02-1.50)

0.77

-1.08

(-1.05-0.89)

0.87

n-DMARD

0.67

(0.49-0.92)

0.01

–

–

–

–

–

–

–

–

Fibromyalgia

0.50

(0.16-1.57)

0.24

1.52

(0.21-2.83)

0.02

–

–

5.31 (-16.36-27.0)

0.63

2.98

(-3.44-9.40)

0.36

HAQ-DI

0.49

(0.29-0.83)

0.008

-0.22

(-0.75-0.32)

0.42

9.48

(1.47-17.52)

0.02

9.61

(0.85-18.38)

0.03

11.93

(8.39-15.47)

0.000

Pain

0.55

(0.31-0.98)

0.04

-0.56

(-1.15-0.03)

0.06

-7.22

(-15.76-1.32)

0.1

-6.21

(-15.3-2.9)

0.18

6.20

(2.0-10.4)

0.004

PGDA

1.07

(0.89-1.30)

0.46

0.19

(-0.007-0.38)

0.06

2.02

(-0.61-4.65)

0.13

2.07

(-0.93-5.06)

0.17

1.84

(0.46-3.21)

0.009

Fatigue

1.99

(0.85-1.16)

0.94

0.10

(-0.09-0.28)

0.3

4.34

(1.78-6.91)

0.001

4.94

(2.16-7.71)

0.001

1.08

(-0.05-2.21)

0.06


Disclosure: G. A. Karpouzas, None; T. Draper, None; E. Hernandez, None; R. Moran, None; S. Ormseth, None.

To cite this abstract in AMA style:

Karpouzas GA, Draper T, Hernandez E, Moran R, Ormseth S. Predictors of Employment, Work Productivity Loss, Activity Impairment, and Regaining Employment in Latinos with Rheumatoid Arthritis in the United States [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/predictors-of-employment-work-productivity-loss-activity-impairment-and-regaining-employment-in-latinos-with-rheumatoid-arthritis-in-the-united-states/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-employment-work-productivity-loss-activity-impairment-and-regaining-employment-in-latinos-with-rheumatoid-arthritis-in-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology